(Q41719431)

8 October 2017

1 reference

title

(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain (English)

1 reference

8 October 2017

Knoll J

1

1 reference

8 October 2017

1 February 1998

1 reference

Basic and Clinical Pharmacology and Toxicology

8 October 2017

1 reference

8 October 2017

82

1 reference

8 October 2017

57-66

1 reference

8 October 2017

2

1 reference

Chemical structure and sympathomimetic action of amines

8 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

Selegiline as initial treatment in de novo parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1998.TB01399.X

10.1111/J.1600-0773.1998.TB01399.X

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9498233